Expert Interview
Evaluating the potential of the new, higher dose version of Eylea in treating Macular Edema
Ticker(s): REGN, RHHBFInstitution: University of Colorado
- Assistant Professor of Ophthalmology at University of Colorado.
- Manages 250 patients a month with macular edema and ~ 150 patients a month with wet AMD.
- Research interests include improving treatment for diabetic eye disease, macular degeneration, and translational research.
Please describe your background and practice setting
Added By: ben_adminHow many patients with Macular Edema do you treat monthly?
Added By: ben_adminWhat are your thoughts on the recent data regarding higher dose versions of Eylea
Added By: ben_adminHow will the higher dose versions of Eylea change your prescribing habits
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
